“We’re the Voice of the HCP”: Danielle Brackenridge on What Makes an MSL Insight Truly Valuable

In medical affairs, the word “insight” gets used constantly.

Teams are asked to collect insights, log insights, escalate insights, and demonstrate the impact of insights. But one of the biggest challenges in the industry is that not everyone agrees on what an insight actually is.

During a conversation with Danielle Brackenridge, an experienced Medical Science Liaison working in multiple sclerosis, one thing became very clear: not every piece of information from the field is an insight.

Some things are simply observations.

Others can completely change strategy.

The Difference Between an Observation and an Insight

Danielle described a high-value insight as “a nugget”, something that could directly change an outcome.